Skip to main content
. 2024 Oct 16;14:24223. doi: 10.1038/s41598-024-76243-x

Fig. 5.

Fig. 5

NORAD acts as a sponge for miR-106a. (A) MiR-106a levels in HUVECs measured by qPCR. (B) A dual-luciferase reporter gene was used to verify the targeted relationship between NORAD and miR-106a. (C) Wound-healing was tested using a scratch assay in HUVECs treated with miR-106a mimic or inhibitor. N = 3–5. *P < 0.05, **P < 0.01.